Correlation Between Acarix AS and Annexin Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Acarix AS and Annexin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acarix AS and Annexin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Acarix AS and Annexin Pharmaceuticals AB, you can compare the effects of market volatilities on Acarix AS and Annexin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acarix AS with a short position of Annexin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acarix AS and Annexin Pharmaceuticals.

Diversification Opportunities for Acarix AS and Annexin Pharmaceuticals

0.35

Correlation Coefficient

Acarix AS  Annexin Pharmaceuticals

Weak diversification

The 3 months correlation between Acarix and Annexin is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Acarix AS and Annexin Pharmaceuticals AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Annexin Pharmaceuticals and Acarix AS is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acarix AS are associated (or correlated) with Annexin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Annexin Pharmaceuticals has no effect on the direction of Acarix AS i.e., Acarix AS and Annexin Pharmaceuticals go up and down completely randomly.

Pair Corralation between Acarix AS and Annexin Pharmaceuticals

Assuming the 90 days trading horizon Acarix AS is expected to generate 0.77 times more return on investment than Annexin Pharmaceuticals. However, Acarix AS is 1.3 times less risky than Annexin Pharmaceuticals. It trades about -0.09 of its potential returns per unit of risk. Annexin Pharmaceuticals AB is currently generating about -0.1 per unit of risk. If you would invest  30.00  in Acarix AS on December 1, 2024 and sell it today you would lose (7.00) from holding Acarix AS or give up 23.33% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Acarix AS  vs.  Annexin Pharmaceuticals AB

Acarix AS

Risk-Adjusted Performance

Very Weak

Over the last 90 days Acarix AS has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in April 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Annexin Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Annexin Pharmaceuticals AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's basic indicators remain comparatively stable which may send shares a bit higher in April 2025. The newest uproar may also be a sign of mid-term up-swing for the firm private investors.

Pair Trading with Acarix AS and Annexin Pharmaceuticals

The main advantage of trading using opposite Acarix AS and Annexin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acarix AS position performs unexpectedly, Annexin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Annexin Pharmaceuticals will offset losses from the drop in Annexin Pharmaceuticals' long position.

The idea behind Acarix AS and Annexin Pharmaceuticals AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.